Sunday, October 24, 2021
- Advertisement -spot_img



Dexamethasone proves to be first drug to save lives of severest COVID-19 cases

Reports suggest that among those who could only breathe with the help of a ventilator, dexamethasone reduced deaths by one third, and by one-fifth in other patients receiving oxygen only.

Dr Reddy’s inks pact with Gilead to manufacture Remdesivir

As per the non-exclusive licensing agreement, Gilead will grant the Hyderabad-based drug maker the right to register and manufacture its investigational drug Remdesivir in 127 countries, Dr Reddy's Laboratories said in a statement.

Doing our best in Covid fight: Eatala

Says Centre guidelines being followed; doctors, healthcare workers risking their lives

COVID-19 can cause dangerous cardiovascular complications

One study, the article authors note, found that almost a quarter of COVID-19 patients - 24 per cent -- were suffering acute heart failure when they were first diagnosed with the coronavirus.

Hyderabad-based Hetero to make Covid drug

Signs deal with Gilead for manufacture, distribution of Remdesivir

Hetero, Gilead Sciences joins hands in Covid fight

Under this licensing deal, Hetero will be supplying Remdesivir in 127 countries, including India, subject to regulatory approvals in respective countries.

Cipla 2nd Indian firm to manufacture, sell antiviral drug remdesivir

Cipla is the second firm after Noida-based Jubilant Life Sciences whose subsidiary Jubilant Generics Ltdhas inked a pact with Gilead Sciences on Tuesday

Gujarat hospitals to join WHO’s ‘Solidarity’ clinical trial

The four drug regimes to be tested on patients are - Remdesivir, Lopinavir, Hydroxychloroquine or Chloroquine and Interferon.

US preparing to treat seriously ill COVID-19 patients with Remdesivir

The medication, recently given fast-track approval for use in the US, could be administered apart from clinical trials as early as Monday to the first coronavirus patients, while manufacturer Gilead is making plans to export it to other nations who give it the green light

US FDA approves emergency use of remdesivir for COVID-19 patients

In an FDA fact sheet for patients and their families and caregivers, the agency on Friday noted that remdesivir has not undergone the same type of review as an FDA-approved or cleared product, reports Xinhua news agency.

Remdesivir: The experimental coronavirus drug

Hyderabad: Simultaneous announcements about remdesivir, the experimental coronavirus drug, ability to treat people with Covid-19 presented conflicting views. Remdesivir is an intravenous, antiviral medicine that...

Research institutes and experts of Hyderabad aid COVID-19 fight

Major scientific institutions and startups of Hyderabad launched multiple initiatives solely aimed at checking the proliferation of Coronavirus and also play their part in the exit strategy of the ongoing lockdown

COVID-19: HCQ efficacy lacks clinical evidence

Senior health officials made clear the need to have more data to understand whether the drug along with other drugs is efficient in treating Covid-19 cases

Race for coronavirus cure

As the world grapples with coronavirus pandemic, researchers are racing against time to find an immediate cure for the disease and also develop a...

‘Existing potential treatment approaches for COVID-19 summarised’

"Cell entry is the first step of cross-species transmission. SARS-CoV-2 is more likely to infect lung type II alveolar cells, which may explain the severe alveolar damage after infection," the scientists wrote in the research.

It’s our business

As we adjust to a life with the coronavirus around us and our habits change, some sectors will bear the brunt and some will benefit

Latest news

- Advertisement -spot_img
Telangana Today